Anthera Pharma (ANTH) Misses Q1 EPS by 1c
Anthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
Anthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.